These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

933 related items for PubMed ID: 28260186

  • 1. Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.
    Omboni S, Malacco E, Napoli C, Modesti PA, Manolis A, Parati G, Agabiti-Rosei E, Borghi C.
    Adv Ther; 2017 Apr; 34(4):784-798. PubMed ID: 28260186
    [Abstract] [Full Text] [Related]

  • 2. Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients.
    Agabiti-Rosei E, Manolis A, Zava D, Omboni S, ZODIAC Study Group.
    Adv Ther; 2014 Feb; 31(2):217-33. PubMed ID: 24415271
    [Abstract] [Full Text] [Related]

  • 3. Fixed-dose combination of zofenopril plus hydrochlorothiazide vs. irbesartan plus hydrochlorothiazide in hypertensive patients with established metabolic syndrome uncontrolled by previous monotherapy. The ZAMES study (Zofenopril in Advanced MEtabolic Syndrome).
    Napoli C, Omboni S, Borghi C, ZAMES (Zofenopril in Advanced MEtabolic Syndrome) Study Group.
    J Hypertens; 2016 Nov; 34(11):2287-97. PubMed ID: 27653164
    [Abstract] [Full Text] [Related]

  • 4. Zofenopril plus hydrochlorothiazide combination in the treatment of hypertension: an update.
    Borghi C, Omboni S.
    Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1055-65. PubMed ID: 25098297
    [Abstract] [Full Text] [Related]

  • 5. Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment: a double-blind, randomized study.
    Modesti PA, Omboni S, Taddei S, Ghione S, Portaluppi F, Pozzilli P, Volpe M, Arca M, Calabrò P, Fulgheri PL, Bucci M, Berra S, Villani GQ, Vladoianu M, Popescu E, Velican VG, Pirvu O.
    J Hypertens; 2016 Mar; 34(3):576-87; discussion 587. PubMed ID: 26703917
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the efficacy and safety of irbesartan/hydrochlorothiazide combination therapy with irbesartan monotherapy in the treatment of moderate or severe hypertension in diabetic and obese hypertensive patients: a post-hoc analysis review.
    Neutel JM.
    Postgrad Med; 2011 Jul; 123(4):126-34. PubMed ID: 21680997
    [Abstract] [Full Text] [Related]

  • 7. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E, Barton J, Nussberger J, Mulcahy D, Jensen C, Dicker P, Stanton A.
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy.
    Rhee MY, Baek SH, Kim W, Park CG, Park SW, Oh BH, Kim SH, Kim JJ, Shin JH, Yoo BS, Rim SJ, Ha JW, Doh JH, Ahn Y, Chae JK, Park JB, Kim SK, Kim CH.
    Drug Des Devel Ther; 2015 May; 9():2847-54. PubMed ID: 26082615
    [Abstract] [Full Text] [Related]

  • 10. Zofenopril plus hydrochlorothiazide: Combination therapy for the treatment of mild to moderate hypertension.
    Zanchetti A, Parati G, Malacco E.
    Drugs; 2006 May; 66(8):1107-15. PubMed ID: 16789795
    [Abstract] [Full Text] [Related]

  • 11. Irbesartan/hydrochlorothiazide for the treatment of isolated systolic hypertension: a subgroup analysis of the INCLUSIVE trial.
    Chrysant SG, Neutel JM, Ferdinand KC, INCLUSIVE investigators.
    J Natl Med Assoc; 2009 Apr; 101(4):300-7. PubMed ID: 19397219
    [Abstract] [Full Text] [Related]

  • 12. Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study.
    Grassi G, Seravalle G, Brambilla G, Dell'Oro R, Trevano FQ, Fici F, van Bortel L, Mancia G.
    Adv Ther; 2017 Jan; 33(12):2173-2187. PubMed ID: 27771847
    [Abstract] [Full Text] [Related]

  • 13. Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: the NINFE (Nebivololo, Irbesartan Nella Funzione Endoteliale) study.
    Vitale C, Marazzi G, Iellamo F, Spoletini I, Dall'Armi V, Fini M, Volterrani M.
    Int J Cardiol; 2012 Mar 08; 155(2):279-84. PubMed ID: 22078979
    [Abstract] [Full Text] [Related]

  • 14. The antihypertensive efficacy of the combination of irbesartan and hydrochlorothiazide assessed by 24-hour ambulatory blood pressure monitoring. Irbesartan Multicenter Study Group.
    Howe P, Phillips P, Saini R, Kassler-Taub K.
    Clin Exp Hypertens; 1999 Nov 08; 21(8):1373-96. PubMed ID: 10574419
    [Abstract] [Full Text] [Related]

  • 15. A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations.
    Bobrie G, Delonca J, Moulin C, Giacomino A, Postel-Vinay N, Asmar R, COmparative Study of Efficacy of Irbesartan/HCTZ with Valsartan/HCTZ Using Home Blood Pressure Monitoring in the TreAtment of Mild-to-Moderate Hypertension (COSIMA) Investigators.
    Am J Hypertens; 2005 Nov 08; 18(11):1482-8. PubMed ID: 16280286
    [Abstract] [Full Text] [Related]

  • 16. Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.
    Melian EB, Jarvis B.
    Drugs; 2002 Nov 08; 62(5):787-816. PubMed ID: 11929332
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome.
    Ghiadoni L, Bruno RM, Cartoni G, Stea F, Magagna A, Virdis A, Grassi D, Ferri C, Taddei S.
    Vascul Pharmacol; 2017 May 08; 92():16-21. PubMed ID: 26070528
    [Abstract] [Full Text] [Related]

  • 18. Comparative efficacy of irbesartan/ hydrochlorothiazide and valsartan/hydrochlorothiazide combination in lowering blood pressure: a retrospective observational study in Oman.
    Al Balushi KA, Habib JQ, Al-Zakwani I.
    Med Princ Pract; 2013 May 08; 22(3):265-9. PubMed ID: 23235349
    [Abstract] [Full Text] [Related]

  • 19. The effects of irbesartan added to hydrochlorothiazide for the treatment of hypertension in patients non-responsive to hydrochlorothiazide alone.
    Rosenstock J, Rossi L, Lin CS, MacNeil D, Osbakken M.
    J Clin Pharm Ther; 1998 Dec 08; 23(6):433-40. PubMed ID: 10048504
    [Abstract] [Full Text] [Related]

  • 20. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A, Calvo C, García-Puig J, Gil-Extremera B, Aguilera MT, de la Sierra A, Martín-Hidalgo A, Marín R, MAPAVEL Investigators (Monitorizacíon Ambulatoria Presión Arterial APROVEL).
    Clin Ther; 2002 Jan 08; 24(1):126-38. PubMed ID: 11833827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.